Aigen Investment Management, LP Gilead Sciences, Inc. Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.64 Million - $2.01 Million	22,978 New	22,978 $1.68 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $741,026 - $808,474	10,022 New	10,022 $751,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $806,588 - $921,331	13,547 New	13,547 $836,000
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $8.34 Million - $10.5 Million	-144,057 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $9.35 Million - $10.6 Million	144,057 New	144,057 $10.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.